Culture Biosciences

The page describes how Culture Biosciences' 250mL bioreactors streamline AAV2 production and ensure comparability with commercial systems for gene therapy development.

Pivot Bio is working to replace synthetic nitrogen fertilizer with a cleaner and more sustainable alternative: nitrogen produced by soil microbes.

The white paper evaluates the Stratyx 250 bioreactor platform across three locations, including two non-Culture Biosciences labs, using a fed-batch HEK cell process to assess consistency across operators, equipment, and SOPs.

Culture Biosciences uses 250-mL and 5-L cloud-based bioreactors for bioprocess modeling.

South San Francisco, CA — December 16, 2025 — Culture Biosciences (“Culture”), a leader in cloud-based biomanufacturing, today announced the successful clo

At BioProcess International, Culture Biosciences shares more about collaboration with ThermoFisher Scientific to evaluate process robustness of their AAV Max platform and AAV9 production system.

Culture's team seeks ways to strengthen team connections and support individual growth between bioreactor runs and product launches.

Culture Biosciences partners with companies as a bioreactor expert, advancing bio culture and upstream innovation with bioreactor systems.

Culture's sales team can be contacted about optimized bioprocess development.

The company offers bioprocessing services (Nexxys), cloud-connected bioreactor software (Console), and mobile laboratory bioreactors (Stratyx).

Culture Biosciences explains how it collects, uses, and protects information from website visitors.

The Terms of Service for Culture Biosciences outline user eligibility, licenses, prohibited conduct, and liability limitations for using the site.

Culture Biosciences appoints Mike Stapleton to its board as it scales its Stratyx hardware platform and Console SaaS offering.

Apr 2026 · Culture BiosciencesNews article

Culture Biosciences closes a Series C financing to accelerate commercial growth of its Stratyx 250 hardware and Console software platform. The financing will support expansion of both offerings.

Dec 2025 · Culture BiosciencesNews article

Xcell Biosciences and Culture Biosciences announce a collaboration to advance cell therapy quality using AI and machine learning. The partnership combines Xcellbio instrumentation with Culture’s cloud-native analysis tools.

Dec 2025 · Culture BiosciencesNews article

Culture Biosciences announces Stratyx 250, a mobile, cloud-integrated bioreactor for cell culture process development. It combines automation, remote process control, and monitoring in a single platform intended for biotech process development, with cloud integration and mobility among its stated features.

Apr 2025 · Culture BiosciencesNews article